Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
La Revue Du Praticien
|
September 17, 2005
[Bullous pemphigoid]
Julie de Quatrebarbes, Pascal Joly
Dermatology (Basel, Switzerland)
|
November 16, 2005
Cetuximab-induced acne
Emmanuel Molinari, Julie De Quatrebarbes, Thierry André, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
February 4, 2011
Atypical nodular panniculitis
Damien Picard, Julie de Quatrebarbes, Isabelle Gueit, et al.
Journal of the American Academy of Dermatology
|
May 21, 2011
Papular and annular fixed urticarial eruption: a characteristic skin manifestation in patients with relapsing polychondritis
Anne-Fleur Tronquoy, Julie de Quatrebarbes, Damien Picard, et al.
Archives of Dermatology
|
September 21, 2005
Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study
Julie de Quatrebarbes, Eric Estève, Martine Bagot, et al.
Oncotarget
|
February 18, 2020
Cetuximab is efficient and safe in patients with advanced cutaneous squamous cell carcinoma: a retrospective, multicentre study
Henri Montaudié, Julien Viotti, Patrick Combemale, et al.
JCO Precision Oncology
|
November 10, 2022
Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort
Manon Girod, Stéphane Dalle, Laurent Mortier, et al.
Melanoma Research
|
November 11, 2024
Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort
Camille Macaire, Wendy Lefevre, Sophie Dalac, et al.
Cancers
|
September 9, 2023
Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients
Constance Reichert, Capucine Baldini, Sarah Mezghani, et al.
Journal of the American Academy of Dermatology
|
June 21, 2021
Late-onset adverse events of anti-PD1 therapy in melanoma patients: An observational study from MELBASE, a nationwide prospective cohort
Clémentine Carlet, Stéphane Dalle, Marie-Thérèse Leccia, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
La Revue Du Praticien
|
September 17, 2005
[Bullous pemphigoid]
Julie de Quatrebarbes, Pascal Joly
Dermatology (Basel, Switzerland)
|
November 16, 2005
Cetuximab-induced acne
Emmanuel Molinari, Julie De Quatrebarbes, Thierry André, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
February 4, 2011
Atypical nodular panniculitis
Damien Picard, Julie de Quatrebarbes, Isabelle Gueit, et al.
Journal of the American Academy of Dermatology
|
May 21, 2011
Papular and annular fixed urticarial eruption: a characteristic skin manifestation in patients with relapsing polychondritis
Anne-Fleur Tronquoy, Julie de Quatrebarbes, Damien Picard, et al.
Archives of Dermatology
|
September 21, 2005
Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study
Julie de Quatrebarbes, Eric Estève, Martine Bagot, et al.
Oncotarget
|
February 18, 2020
Cetuximab is efficient and safe in patients with advanced cutaneous squamous cell carcinoma: a retrospective, multicentre study
Henri Montaudié, Julien Viotti, Patrick Combemale, et al.
JCO Precision Oncology
|
November 10, 2022
Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort
Manon Girod, Stéphane Dalle, Laurent Mortier, et al.
Melanoma Research
|
November 11, 2024
Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort
Camille Macaire, Wendy Lefevre, Sophie Dalac, et al.
Cancers
|
September 9, 2023
Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients
Constance Reichert, Capucine Baldini, Sarah Mezghani, et al.
Journal of the American Academy of Dermatology
|
June 21, 2021
Late-onset adverse events of anti-PD1 therapy in melanoma patients: An observational study from MELBASE, a nationwide prospective cohort
Clémentine Carlet, Stéphane Dalle, Marie-Thérèse Leccia, et al.
Page
of 3